Effect of clopidogrel on the rate and functional severity of stroke among high vascular risk patients: a prespecified substudy of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance (CHARISMA) trial.
about
Effect of clopidogrel on the rate and functional severity of stroke among high vascular risk patients: a prespecified substudy of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance (CHARISMA) trial.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Effect of clopidogrel on the r ...... nd Avoidance (CHARISMA) trial.
@en
Effect of clopidogrel on the r ...... nd Avoidance (CHARISMA) trial.
@nl
type
label
Effect of clopidogrel on the r ...... nd Avoidance (CHARISMA) trial.
@en
Effect of clopidogrel on the r ...... nd Avoidance (CHARISMA) trial.
@nl
prefLabel
Effect of clopidogrel on the r ...... nd Avoidance (CHARISMA) trial.
@en
Effect of clopidogrel on the r ...... nd Avoidance (CHARISMA) trial.
@nl
P2093
P50
P1433
P1476
Effect of clopidogrel on the r ...... nd Avoidance (CHARISMA) trial.
@en
P2093
CHARISMA Trial Investigators
J Donald Easton
Jean-Louis Mas
Keith A A Fox
S Claiborne Johnston
Werner Hacke
P304
P356
10.1161/STROKEAHA.110.586727
P407
P577
2010-07-01T00:00:00Z